148 related articles for article (PubMed ID: 619140)
1. Synthesis and some pharmacological properties (4-beta-(2-thienyl)-L-alanine)oxytocin.
Smith CW; Skala G; Walter R
J Med Chem; 1978 Jan; 21(1):115-7. PubMed ID: 619140
[TBL] [Abstract][Full Text] [Related]
2. Replacement of the disulfide bond in oxytocin by an amide group. Synthesis and some biological properties of (cyclo-(1-L-aspartic acid,6-L-alpha,beta-diaminopropionic acid))oxytocin.
Smith CW; Walter R; Moore S; Makofske RC; Meienhofer J
J Med Chem; 1978 Jan; 21(1):117-20. PubMed ID: 619141
[TBL] [Abstract][Full Text] [Related]
3. Conformation-activity studies of oxytocin. Effects of structural modifications at corner positions of the beta-turns on the uterotonic activity.
Smith CW; Botos CR; Skala G; Walter R
J Med Chem; 1977 Nov; 20(11):1457-60. PubMed ID: 915905
[TBL] [Abstract][Full Text] [Related]
4. Pharmacological effects of introducing a double bond into a binding site of oxytocin. Analogues with L-3,4-dehydroproline in position 7.
Moore S; Felix AM; Meienhofer J; Smith CW; Walter R
J Med Chem; 1977 Apr; 20(4):495-500. PubMed ID: 850234
[TBL] [Abstract][Full Text] [Related]
5. Oxytocin and lysine-vasopressin with N5,N5-dialkylglutamine in the 4 position: effect of introducing sterically hindered groups into the hydrophilic cluster of neurohypophyseal hormones.
Stahl GL; Smith CW; Walter R; Tsegenidis T; Stavropoulos G; Cordopatis P; Theodoropoulos D
J Med Chem; 1980 Feb; 23(2):213-7. PubMed ID: 7359537
[TBL] [Abstract][Full Text] [Related]
6. Oxytocin analogues with combined high smooth muscle and negligible antidiuretic activities. Investigation of position 7 in neurohypophyseal hormones.
Walter R; Smith CW; Roy J; Formento A
J Med Chem; 1976 Jun; 19(6):822-5. PubMed ID: 985884
[TBL] [Abstract][Full Text] [Related]
7. Effect of changing the COOH-terminal amide group present in the hydrophilic cluster of oxytocin to dimethylamide.
Ting YF; Smith CW; Stahl GL; Walter R; Cordopatis P; Theodoropoulos D
J Med Chem; 1980 Jun; 23(6):693-5. PubMed ID: 7392037
[TBL] [Abstract][Full Text] [Related]
8. Active-site studies of neurohypophyseal hormones: synthesis and pharmacological properties of [5-(N4,N4-dimethylasparagine)]oxytocin.
Walter R; Stahl GL; Caplaneris T; Cordopatis P; Theodoropoulos D
J Med Chem; 1979 Jul; 22(7):890-3. PubMed ID: 448689
[TBL] [Abstract][Full Text] [Related]
9. (4-Phenylalanine)oxytocin, an inhibitor of the antidiuretic effect of 8-arginine-vasopressin.
Nestor JJ; Ferger MF; Chan WY
J Med Chem; 1975 Oct; 18(10):1022-4. PubMed ID: 1159680
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and some pharmacological properties of [1-beta-mercapto-beta,beta-diethylpropionic acid,2-(3,5-dibromo-L-tyrosine)]oxytocin.
Lundell EO; Smith CW; Ferger MF
J Med Chem; 1975 Dec; 18(12):1262-4. PubMed ID: 1195281
[TBL] [Abstract][Full Text] [Related]
11. Biofunctional evaluation of a hydrogen bond linking the ring and tail beta-turns of oxytocin.
Roy J; Roy U; Gazis DC; Schwartz IL
Proc Natl Acad Sci U S A; 1979 Jul; 76(7):3309-13. PubMed ID: 291004
[TBL] [Abstract][Full Text] [Related]
12. (1-Beta-mercaptopropionic acid, 2-(3,5-dibromo-L-tyrosine))oxytocin, a potent inhibitor of oxytocin.
Lundell EO; Ferger MF
J Med Chem; 1975 Oct; 18(10):1045-7. PubMed ID: 1159688
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and some pharmacological properties of [Glu(OMe)4]oxytocin and [Mpr1, Glu(OMe)4]oxytocin.
Photaki I; Tzougraki C; Kotsira-Engonopoulos C
Int J Pept Protein Res; 1979 Apr; 13(4):426-33. PubMed ID: 457336
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and pharmacological properties of [1-L-penicillamine,4-L-leucine]oxytocin.
Ferger MF; Chan WY
J Med Chem; 1975 Oct; 18(10):1020-2. PubMed ID: 1159679
[TBL] [Abstract][Full Text] [Related]
15. Synthetic metabolites of neurohypophyseal hormones. (Des-9-glycinamide)oxytocin and (des-9-glycinamide, des-8-leucine)oxytocin.
Walter R; Havran RT; Schwartz IL
J Med Chem; 1976 Feb; 19(2):328-30. PubMed ID: 1249815
[TBL] [Abstract][Full Text] [Related]
16. Antagonists of oxytocin featuring replacement with modified beta-mercaptopropionic acids at position 1.
Flouret G; Majewski T; Balaspiri L; Brieher W; Mahan K; Chaloin O; Wilson L; Slaninová J
J Pept Sci; 2002 Jul; 8(7):314-26. PubMed ID: 12148781
[TBL] [Abstract][Full Text] [Related]
17. Combined high oxytocic with negligible antidiuretic and pressor activities in multisubstituted oxytocins.
Stahl GL; Walter R
J Med Chem; 1977 Apr; 20(4):492-5. PubMed ID: 850233
[TBL] [Abstract][Full Text] [Related]
18. A ureido group containing analogue of oxytocin comprising eight amino acid residues.
Bodanszky M; Fagan DT; Walter R; Smith CW
J Med Chem; 1978 Mar; 21(3):306-8. PubMed ID: 628007
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and some pharmacological properties of five analogs of oxytocin having L-homocysteine in position 6.
Smith CW; Ferger MF
J Med Chem; 1976 Feb; 19(2):250-4. PubMed ID: 1249804
[TBL] [Abstract][Full Text] [Related]
20. Oxytocin analogs with oxygen-containing side chains in position 3.
Gazis D; Schwartz IL; Cordopatis P; Theodoropoulos D
Int J Pept Protein Res; 1986 Jun; 27(6):679-84. PubMed ID: 3759339
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
